Nefazodone and Nerandomilast: Interaction Details

Brand names
Nefazodone
Serzone
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Nerandomilast

We don't have a drug information page for Nerandomilast yet. Have a question about Nerandomilast? Ask a pharmacist, free →

What Happens When You Take Nefazodone With Nerandomilast

What can happen when they are taken together (rated Major)

Increased nerandomilast exposure and an increased risk of nerandomilast-related adverse reactions

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Nerandomilast is a , so taking it together with a strong CYP3A can raise nerandomilast exposure and, in turn, the likelihood of adverse reactions related to it. When a strong CYP3A inhibitor is used at the same time, the nerandomilast dosage should be lowered to 9 mg twice daily. In drug interaction studies, itraconazole (a strong CYP3A inhibitor) given as a 200 mg oral solution once daily for 4 days alongside nerandomilast raised nerandomilast 1.3-fold and 2.2-fold.1

The Nefazodone and Nerandomilast Interaction, Explained

Nefazodone can raise the amount of nerandomilast in your body. Nefazodone slows down , a liver enzyme that helps clear nerandomilast. With less clearing, more of the medicine stays in your blood, which can make nerandomilast side effects more likely. In a study with a similar strong enzyme blocker, the total amount of nerandomilast in the body was about 2.2 times higher.

Please keep taking both medicines as prescribed and don't change anything on your own. Your pharmacist or doctor can lower your nerandomilast dose and check on you, so this combination can be managed safely.

Mechanism: Nefazodone is a strong . Nerandomilast is a CYP3A , so of CYP3A-mediated increases nerandomilast exposure. Neither drug's activity depends on activation, so the direction is increased exposure.

  • Magnitude: With itraconazole (strong CYP3A inhibitor), nerandomilast rose 1.3-fold and 2.2-fold. Nefazodone-specific data are not cited, so this is extrapolated by class.
  • Onset: unspecified. Evidence: probable.
  • Management: Reduce nerandomilast to 9 mg twice daily with strong CYP3A . Monitor for nerandomilast-related adverse reactions.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Nefazodone and Nerandomilast Interact

The likely mechanism

of -mediated of nerandomilast

In short: Nefazodone slows CYP3A, an enzyme that breaks down nerandomilast, so nerandomilast can build up in the body.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When One Drug Raises Another’s Level”, one chapter of our one-minute explainer. See how it works 

How to Manage the Nefazodone and Nerandomilast Interaction

Your care team can handle this by adjusting the nerandomilast dose while you take nefazodone.

  • The documented approach is to lower nerandomilast to 9 mg twice daily when it is used with strong like nefazodone.
  • Your team may monitor you more closely for side effects.
  • Keep taking both medicines as prescribed. Do not change doses yourself.
  • Tell your pharmacist or prescriber about any new or worsening symptoms, and about any changes to your medicines, including starting or stopping nefazodone.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Nefazodone or Nerandomilast need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: JASCAYD oral tablets, nerandomilast oral tablets

    In drug interaction studies, giving nerandomilast together with itraconazole (a strong ) as a 200 mg oral solution once daily for 4 days raised the of nerandomilast 1.3-fold and its 2.2-fold.1

Nefazodone and Nerandomilast: Common Questions

How serious is the Nefazodone and Nerandomilast interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Nefazodone and Nerandomilast interaction managed?

Your care team can handle this by adjusting the nerandomilast dose while you take nefazodone. The documented approach is to lower nerandomilast to 9 mg twice daily when it is used with strong like nefazodone. Your team may monitor you more closely for side effects. Keep taking both medicines as prescribed. Do not change doses yourself. Tell your pharmacist or prescriber about any… Management is individual — always follow your own care team's guidance.

Does taking Nefazodone and Nerandomilast at different times of day help?

No. Taking them at different times of day does not prevent this one. Nefazodone slows , an enzyme that breaks down nerandomilast, so nerandomilast can build up in the body. That change lasts while nefazodone is being taken and can continue for a while after the last dose.

Your pharmacist or prescriber can tell you how they will manage it.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Nefazodone and Nerandomilast Interaction

Ask in your own words about taking Nefazodone and Nerandomilast together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: JASCAYD® oral tablets, nerandomilast oral tablets. Boehringer Ingelheim Pharmaceuticals, Inc. (per FDA), Ridgefield, CT, 2026. DailyMed
Was this write-up helpful?

Other Serious Interactions of Nefazodone and Nerandomilast

Also serious with Nefazodone

Also serious with Nerandomilast

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Nefazodone

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.